12 Jun Hexa-halers
Primary Partner – Alder Hey Children’s NHS Foundation Trust
Hexa-halers have created a novel range of patented inhalers that will address the serious issue of poor compliance and adherence within asthmatic groups.
The original L inhaler was developed over 50 years ago and even though lives have changed significantly, the design of the inhaler hasn’t. This lack of modernisation has created the desire and market for the Hexa-halers range of devices.
Founded in 2018 the company have created the first ‘desirable inhaler’, addressing lots of inhaler little niggles, that will appeal to a wide range of sufferers. The company initially focused on children and adolescents, but they have been shown to appeal to a wide range of age groups.
Approaching the programme
The company were keen to work with organisations that were interested in challenging existing methodology and be part of an exciting development journey of their inhalers that would ensure the product is validated by professionals.
HIE was one of the support programmes that Hexa-halers was made aware of through the Knowledge Transfer Network. Initial meetings with programme partner Liverpool City Region LEP was followed by an introduction review meeting to assess initial suitability. The company were then introduced to partners Alder Hey Children’s NHS Foundation Trust to discuss the validity of their product.
The programme has helped connect the company with key personnel within the respiratory departments at Alder Hey Children’s NHS Foundation Trust. This has included a critical review of the device, where it should go and what Alder Hey could do to help.
By having a receptive meeting with clinicians, they were able to plan what data Alder Hey would be able to collect which has resulted in a grant application for some important validation work to be carried out to create a body of research.
Well-regarded names in their field also reviewed the device, its potential impact and possible thoughts moving forward which has enabled the company to obtain quotes for grants applied for.
The work with Alder Hey Children’s NHS Foundation Trust has created the first chapter in the body of evidence needed to establish MHRA (Medicines and Healthcare products Regulatory Agency) approval. The positive response from professionals has also been a useful yard stick to assess the value of the device.
Hexa-Halers also credits the programme with effective communication of the product.